Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PPP2R3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FRMD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ADAM22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCAT18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101928718 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928076 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM59L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FNTA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLCB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DERL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01128 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRYGD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on